CD34 and graft versus host disease: A total number of 6.958 × 106/kg mobilized peripheral CD34 + cells were infused intravenously over 3 consecutive days, and cyclosporine + MMF + short term MTX were administered for graft-versus-host disease (GVHD) prevention.